LungAI
Overview
Oatmeal Health’s LungAI is an advanced AI software solution specifically designed to enhance lung cancer screening programs for physicians and healthcare professionals. This platform integrates seamlessly with existing chest CT computer-aided detection (CADe) systems, providing a sophisticated tool for pulmonary nodule risk assessment.
LungAI leverages a multi-faceted approach to generate malignancy risk scores, incorporating:
- Detailed Imaging Features: Analyzing characteristics of pulmonary nodules from CT scans.
- Temporal Analysis: Comparing current imaging with prior examinations to track changes over time.
- Patient Demographics: Integrating relevant patient information to refine risk predictions.
By operating within supported CADe software already familiar to radiologists, LungAI avoids disrupting established workflows. Its primary goal is to assist lung cancer screening programs by:
- Identifying higher-risk patients more effectively.
- Standardizing the process of malignancy risk assessment.
- Facilitating appropriate and timely follow-up pathways for patients.
Beyond risk assessment, Oatmeal Health is also developing operational and navigation workflows to help health systems improve patient follow-up within lung cancer screening programs, ensuring a more comprehensive and structured approach to early detection and management.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-based pulmonary nodule malignancy risk assessment
- Temporal comparison using prior CT examinations
- Whole-lung image analysis
- Patient demographic integration
- Integration with supported CADe platforms
- Lung cancer screening workflow support
- Clinical follow-up and navigation infrastructure
- Designed for radiology and lung screening programs
Use Cases
- Lung cancer screening programs
- Pulmonary nodule risk assessment
- Standardizing risk assessment in radiology
- Improving patient follow-up for lung cancer screening
- Supporting radiologists in interpreting chest CTs
- Enhancing clinical workflow for lung screening
What Physicians Need to Know
LungAI offers a second opinion on low-dose lung CTs, which can assist in lung cancer screening. It's important to integrate this AI-assisted detection into existing workflows for optimal benefit.
The provided text does not specify details regarding DICOM support, PACS integration methods, AI model architecture, processing speed, FDA clearance pathway, sensitivity & specificity data, or RSNA/ACR validation.
Details
| Category | Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Cloud-based. Oatmeal Health uses Google Cloud to spin up secure environments, run large-scale model training, and deploy their reimbursable lung cancer diagnostic. |
| Mobile App | No explicit mention of a mobile app for patients or providers. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status | Pending. lungai is a medical device pending fda 510(k) clearance. oatmeal health anticipates being among the first fda-cleared ai solutions for lung cancer screening. AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology, Pulmonology, Radiology |
Support & Reliability
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate LungAI
Videos
Product demos, reviews, and walkthroughs for LungAI.
Jonathan Govette, Co-Founder and CEO - Oatmeal Health: Investor Preview, AI Cancer Screening Startup
Jonathan Govette, CEO of Oatmeal Health




